View all news

ALERT: 18 ResMed-supported Studies Featured at ATS 2022 Conference

05/12/2022

What’s happening

ResMed is supporting 18 clinical study abstracts presented at the ATS 2022 International Conference. Research expands our knowledge of:

  • Obstructive sleep apnea (OSA) patient management
  • COPD patient management, links between COPD, other diseases
  • Asthma patient management (including pediatric asthma) 
  • Global smoking prevalence

When: Saturday, May 13–Wednesday, May 18, 2022
Where: The Moscone Center | 747 Howard St, San Francisco, CA 94103
Available for interviews:

  • Adam Benjafield, PhD; VP, Medical Affairs, ResMed
  • Meredith Barrett, PhD; VP, Medical Affairs, ResMed
  • Atul Malhotra, MD; Research Chief of Pulmonary, Critical Care, and Sleep 
    Medicine, University of California San Diego

To schedule interviews:

  • Kristin Deuber, +1 614.975.4186, resmed@allisonpr.com 

Abstracts (complete list, by topic):

Topic

Subject

Date/Time

Location

OSA

Lipid mgmt. in patients w/ OSA, coronary artery disease

May 15, 2:15-3:45p

Room 2022/2024

When to intervene: PAP users with OSA, comorbidities*

May 16, 9:30-11a

Room 303-304

Heart risk in patients w/ OSA, acute coronary syndrome

May 16, 9:30-11a

Room 303-304

AirSense 11: User experience on ResMed’s new PAP*

May 16, 11:15a-1:15p

Hall F, Area A

PAP use of patients remotely diagnosed and managed**

May 16, 11:15a-1:15p

Hall F, Area A

Predicting PAP users’ healthcare resource utilization*

May 16, 2:15-3:45p

Room 2022/2024

Blood pressure variability during PAP withdrawal

May 16, 2:15-3:45p

Room 2022/2024

OSA’s and PAP’s effects on ACS patients’ blood pressure

May 17, 9:30-9:40a

Room 3014

PAP’s effects on cognition, mild cognitive impairment

May 18, 9:05-9:15a

Room 2006/2008

PAP dose-response relationship with clinical outcomes

May 18, 9:15-9:25a

Room 2006/2008

Healthy-user effect in PAP-adherent in people with OSA*

May 18, 9:25-9:35a

Room 2006/2008

COPD

Early detection of COPD exacerbations

May 15, 11:15a-1:15p

Hall F, Area C

Prevalence of comorbidities in adults with COPD*

May 18, 8:15-9:45a

Room 303-304

Asthma

Prevalence of comorbidities in adults with asthma*

May 15, 11:15a-1:15p

Hall F, Area C

Validation of wearable to monitor children*

May 15, 11:15a-1:15p

Hall F, Area E

Financial incentives to improve adolescent adherence

May 16, 9:30-11a

Room 2005/2007

Self-reported vs. digitally captured inhaler use data*

May 17, 2:15-3:45p

Room 3016/3018

Smoking

Global projections of smoking prevalence trends*

May 15, 9:30-11a

Room 303-304

* Presented by a ResMed employee; others presented by non-ResMed key opinion leaders
** Presented by Primasun, a joint venture between ResMed and Verily, an Alphabet company

# # #

 


 

Multimedia Files:

View all news